Abstract
Resistance to hormonal therapy frequently occurs following successful treatment in breast cancer. The mechanism responsible for this acquired resistance is still unknown. It has been suggested that a hypoxic tumor microenvironment promotes malignant progression of cancer, i.e., hypoxia may promote estrogen‐independent growth (a more malignant phenotype) of breast cancer. To clarify this hypothesis, the effects of hypoxia on the growth responses to hormonal agents and the expression levels of estrogen receptor (ER)‐α and progesterone receptor (PgR) were investigated in two human breast cancer cell lines, ML‐20 and KPL‐1. The expression level of ER‐α was significantly decreased by hypoxia (1% O2) in a tune‐dependent manner in both cell lines. Hypoxia also significantly reduced the growth‐promoting effect of estradiol (E2) and the growth‐inhibitory effects of an antiestrogen, ICI 182 780, and a progestin, medroxyprogesterone acetate, in both cell lines. In addition, hypoxia markedly suppressed the induction of PgR mRNA and protein by E2 in both cell lines. To clarify further the effect of hypoxia on ER‐α expression, the expression levels of hypoxia‐inducible factor‐la (HIF‐lα), a marker of hypoxia and ER‐α were immunohistochemically examined in 36 breast cancer specimens. ER‐α expression (both its proportion and intensity) was significantly lower in nuclear HIF‐lα‐positive tumors than in negative tumors. These findings indicate that hypoxia down‐regulates ER‐α expression as well as ER‐α function in breast cancer cells. These processes may lead to an acquired resistance to hormonal therapy in breast cancer
Keywords: Hypoxia, Breast cancer, Estrogen receptor, Hypoxia‐inducible factor‐1α, Hormone resistance
Full Text
The Full Text of this article is available as a PDF (1.2 MB).
REFERENCES
- 1. ) Katzenellenbogen , B. S. , Montano , M. M. , Ekena , K. , Herman , M. E. and Mclnerney , E. M.William L.McGuireMemorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer . Breast Cancer Res. Treat. , 44 , 23 – 38 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 2. ) McLeskey , S. W. , Kurebayashi , J. , Honig , S. F. , Zwiebel , J. , Lippman , M. E. , Dickson , R. B. and Kern , F. G.Fibro‐blast growth factor 4 transfection of MCF‐7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen‐treated athymic nude mice . Cancer Res. , 53 , 2168 – 2177 ( 1993. ). [PubMed] [Google Scholar]
- 3. ) McLeskey , S. W. , Zhang , L. , Kharbanda , S. , Kurebayashi , J. , Lippman , M. E. , Dickson , R. B. and Kern , F. G.Fibro‐blast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis . Breast Cancer Res. Treat. , 39 , 103 – 117 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Kurebayashi , J. , Otsuki , T. , Yamamoto , S. , Kurosumi , M. , Nakata , T. , Akinaga , S. and Sonoo , H.A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen‐resistant KPL‐1 human breast cancer cells in vivo but not in vitro . Oncology , 55 ( Suppl. 1 ), 23 – 34 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Kurebayashi , J. , Kunisue , H. , Yamamoto , S. , Kurosumi , M. , Otsuki , T. and Sonoo , H.Paradoxical hormone responses of KPL‐1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth . Oncology , 59 , 158 – 165 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Semenza , G. L.Hypoxia, clonal selection, and the role of HIF‐1 in tumor progression . Crit. Rev. Biochem. Mol. Biol. , 35 , 71 – 103 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Zhong , H. , De Marzo , A. M. , Laughner , E. , Lim , M. , Hilton , D. A. , Zagzag , D. , Buechler , P. , Isaacs , W. B. , Semenza , G. L. and Simons , J. W.Overexpression of hypoxia‐inducible factor 1alpha in common human cancers and their metastases . Cancer Res. , 59 , 5830 – 5835 ( 1999. ). [PubMed] [Google Scholar]
- 8. ) Talks , K. L. , Turley , H. , Gatter , K. C. , Maxwell , P. H. , Pugh , C. W. , Ratcliffe , P. J. and Harris , A. L.The expression and distribution of the hypoxia‐inducible factors HIF‐2alpha and HIF‐2alpha in normal human tissues, cancers, and tumor‐associated macrophages . Am. J. Pathol. , 157 , 411 – 421 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. ) Zagzag , D. , Zhong , H. , Scalzitti , J. M. , Laughner , E. , Simons , J. W. and Semenza , G. L.Expression of hypoxia‐inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression . Cancer , 88 , 2606 – 2618 ( 2000. ). [PubMed] [Google Scholar]
- 10. ) Ryan , H. E. , Poloni , M. , McNulty , W. , Elson , D. , Gassmann , M. , Arbeit , J. M. and Johnson , R. S.Hypoxia‐inducible factor‐1alpha is a positive factor in solid tumor growth . Cancer Res. , 60 , 4010 – 4015 ( 2000. ). [PubMed] [Google Scholar]
- 11. ) Birner , P. , Schindl , M. , Obermair , A. , Plank , C. , Breitenecker , G. and Oberhuber , G.Overexpression of hypoxia‐inducible factor 1alpha is a marker for an unfavorable prognosis in early‐stage invasive cervical cancer . Cancer Res. , 60 , 4693 – 4696 ( 2000. ). [PubMed] [Google Scholar]
- 12. ) Brown , J. M.The hypoxic cell: a target for selective cancer therapy‐eighteenth Bruce F. Cain Memorial Award lecture . Cancer Res. , 59 , 5863 – 5870 ( 1999. ). [PubMed] [Google Scholar]
- 13. ) Bos , R. , Zhong , H. , Hanrahan , C. R , Mommers , E. C. M. , Semenza , G. L. , Pinedo , H. M. , Abeloff , M. D. , Simons , J. W. , van Diest , P. J. and van der Wall , E.Levels of hypoxia‐inducible factor‐1alpha during breast carcinogenesis . J. Natl. Cancer Inst. , 93 , 309 – 314 ( 2001. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Kurebayashi , J. , McLeskey , S. W. , Johnson , M. D. , Lippman , M. E. , Dickson , R. B. and Kern , F. G.Quantitative demonstration of spontaneous metastasis by MCF‐7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ . Cancer Res. , 53 , 2178 – 2187 ( 1993. ). [PubMed] [Google Scholar]
- 15. ) Kurebayashi , J. , Kurosumi , M. and Sonoo , H.A new human breast cancer cell line, KPL‐1 secretes tumour‐associated antigens and grows rapidly in female athymic nude mice . Br. J. Cancer , 71 , 845 – 853 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) McLeskey , S. W. , Zhang , L. , El‐Ashry , D. , Track , B. J. , Lopez , C. A. , Kharbanda , S. , Tobias , C. A. , Lorant , L. A. , Hannum , R. S. , Dickson , R. B. and Kern , F. G.Tamoxifenresistant fibroblast growth factor‐transfected MCF‐7 cells are cross‐resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors . Clin. Cancer Res. , 4 , 697 – 711 ( 1998. ). [PubMed] [Google Scholar]
- 17. ) Otsuki , T. , Yamada , O. , Kurebayashi , J. , Moriya , T. , Sakaguchi , H. , Kunisue , H. , Yata , K. , Uno , M. , Yawata , Y. and Ueki , A.Estrogen receptors in human myeloma cells . Cancer Res. , 60 , 1434 – 1441 ( 2000. ). [PubMed] [Google Scholar]
- 18. ) Harvey , J. M. , Clark , G. M. , Osborne , C. K. and Allred , D. C.Estrogen receptor status by immunohistochemistry is superior to the ligand‐binding assay for predicting response to adjuvant endocrine therapy in breast cancer . J. Clin. Oncol. , 17 , 1474 – 1481 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Mazure , N. M. , Chen , E. Y. , Yeh , P. , Laderoute , K. R. and Giaccia , A. J.Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression . Cancer Res. , 56 , 3436 – 3840 ( 1996. ). [PubMed] [Google Scholar]
- 20. ) Forsythe , J. A. , Jiang , B. H. , Iyer , N. V. , Agani , F. , Leung , S. W. , Koos , R. D. and Semenza , G. L.Activation of vascular endothelial growth factor gene transcription by hypoxia‐inducible factor 1 . Mol. Cell. Biol. , 16 , 4604 – 4613 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. ) Poller , D. N. , Snead , D. R. , Roberts , E. C. , Galea , M. , Bell , J. A. , Gilmour , A. , Elston , C. W. , Blamey , R. W. and Ellis , I. O.Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c‐erbB‐2 oncoprotein . Br. J. Cancer , 68 , 156 – 161 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. ) Knight , W. A. , Livingston , R. B. , Gregory , E. J. and McGuire , W. L.Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer . Cancer Res. , 37 , 4669 – 4671 ( 1977. ). [PubMed] [Google Scholar]
- 23. ) Gasparini , G. , Toi , M. , Miceli , R. , Vermeulen , P. B. , Dittadi , R. , Biganzoli , E. , Morabito , A. , Fanelli , M. , Gatti , C. , Suzuki , H. , Tominaga , T. , Dirix , L. Y. and Gion , M.Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node‐positive breast cancer treated with either adjuvant chemotherapy or hormone therapy . Cancer J. Sci. Am. , 5 , 101 – 111 ( 1999. ). [PubMed] [Google Scholar]
- 24. ) Gagliardi , A. and Collins , D. C.Inhibition of angiogenesis by antiestrogens . Cancer Res. , 53 , 533 – 535 ( 1993. ). [PubMed] [Google Scholar]
- 25. ) Evans , S. M. , Koch , C. J. , Laughlin , K. M. , Jenkins , W. T. , Van Winkle , T. and Wilson , D. F.Tamoxifen induces hypoxia in MCF‐7 xenografts . Cancer Res. , 57 , 5155 – 5161 ( 1997. ). [PubMed] [Google Scholar]
- 26. ) Oikawa , T. , Hiragun , A. , Yoshida , Y. , Ashino‐Fuse , H. , Tominaga , T. and Iwaguchi , T.Angiogenic activity of rat mammary carcinomas induced by 7,12‐dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition . Cancer Lett. , 43 , 85 – 92 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 27. ) Brown , J. M.Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies . Mol. Med. Today , 6 , 157 – 162 ( 2000. ). [DOI] [PubMed] [Google Scholar]